11:00 - 11:20 amSunday, September 7
Plenary Hall
The renaissance in medicine: Going digital
Plenary Hall
The renaissance in medicine: Going digital
Digital Health Director, Claremont Creek Ventures
Human beings are big data. Analogous to computer code, human beings are uniquely defined by the information content held within the body and more specifically, how that information is interconnected. As... Read more

Description

Human beings are big data. Analogous to computer code, human beings are uniquely defined by the information content held within the body and more specifically, how that information is interconnected. As medical data continues to explode and become increasingly digital, the vast amount of information that is able to be collected presents significant opportunities to improve the nature of medicine and care.

This not only includes developing a deep understanding a person's genome, but also a person's epigenome, microbiome, and virome. Many of these sources of big data are ever-changing due to factors such as age, diet, and environment. Currently, EHRs and other medical technologies are beginning to allow us to collect and capture this information, but the future of medicine is synonymous with our technology's ability to translate this data into personalized understandings and solutions. This informatics revolution has the potential to spawn significant advancements in early predictions and diagnoses, targeted therapies, generalized therapies, and even engineered genetics.

In short, the influx of patient data and decoded genetics has turned modern medical issues into Big Data problems. In the future the Hippocratic Oath will require doctors to take this genetic variability into account, which poses a number of ethical questions and concerns.

This discussion aims to dissect the revolution of personalized medicine, and more specifically how big data and our decoded genomics will change the nature of disease, healthcare diagnoses, treatment, and regulation.  

Ted Driscoll is Director of Digital Health at Claremont Creek Ventures. He is also an active angel investor in the Life Science Angels and a founding director of the Sand Hill Angels. Prior to his venture capital experience, Ted helped found five successful companies in imaging-related markets. He was founder and CEO of Be Here Technologies, a pioneer in Internet, Broadcast and Videoconferencing technologies. He served as a Division President and CTO of Diasonics, with responsibility for its MRI, ultrasound, digital X-ray, lithotripsy and acoustic ablation technology areas. He had earlier directed the Diasonics technology team that developed the first commercial MRI scanners and numerous advances in MR imaging. Previously, Ted was also Vice President of Engineering and R&D of Identix, now a world leader in fingerprint and face recognition; and Director of R&D at International Imaging Systems, an early pioneer in remote sensing. His research and patents in ultrasound therapy and acoustic hemostasis also led to the founding of another company, Therus, now partnered with Boston Scientific.

Ted holds a PhD from Stanford University in Digital Imaging, Masters degrees from Harvard University in Computer Graphics and Remote Sensing and a Bachelor's degree from the University of Pennsylvania. Ted holds 40+ granted US and foreign patents in image-related fields, with approximately 30 additional pending applications. 

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search